These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 709557)
1. Amphotericin B and combination chemotherapy in the treatment of refractory metastatic breast carcinoma and sarcoma. Krutchik AN; Buzdar AU; Blumenschein GR; Sinkovics JG Cancer Treat Rep; 1978 Oct; 62(10):1565-7. PubMed ID: 709557 [TBL] [Abstract][Full Text] [Related]
2. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer. Klaassen U; Wilke H; Seeber S Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897 [TBL] [Abstract][Full Text] [Related]
3. A five-drug combination in the treatment of metastatic breast cancer. Falkson G; Falkson HC Cancer Clin Trials; 1981; 4(1):81-5. PubMed ID: 7214665 [TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas. Yap BS; Baker LH; Sinkovics JG; Rivkin SE; Bottomley R; Thigpen T; Burgess MA; Benjamin RS; Bodey GP Cancer Treat Rep; 1980 Jan; 64(1):93-8. PubMed ID: 7379060 [TBL] [Abstract][Full Text] [Related]
5. Sequential use of endocrine therapy and chemotherapy for metastatic breast cancer: effects on survival. Manni A; Trujillo JE; Pearson OH Cancer Treat Rep; 1980 Jan; 64(1):111-6. PubMed ID: 6155207 [TBL] [Abstract][Full Text] [Related]
6. Results of the Royal Marsden Hospital second soft tissue sarcoma schedule (STS II) chemotherapy regimen in the management of advanced sarcoma. Bryant BM; Wiltshaw E Cancer Treat Rep; 1980; 64(4-5):689-92. PubMed ID: 7000348 [TBL] [Abstract][Full Text] [Related]
7. First, second and third line chemotherapy programs in metastatic breast carcinoma. Rizel S; Sulkes A; Gez E; Brufman G; Biran S Isr J Med Sci; 1981; 17(9-10):946-53. PubMed ID: 6171542 [TBL] [Abstract][Full Text] [Related]
8. [Palliative chemotherapy of adult soft tissue sarcomas with an association of cyclophosphamide-vincristine-adriamycine-dacarbazine (CYVADIC) (author's transl)]. Bui B; Chauvergne J; Durand M; Brunet R Bull Cancer; 1981; 68(1):1-5. PubMed ID: 7225604 [TBL] [Abstract][Full Text] [Related]
9. Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast. Smalley RV; Murphy S; Huguley CM; Bartolucci AA Cancer Res; 1976 Nov; 36(11 Pt 1):3911-6. PubMed ID: 975039 [TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in advanced breast carcinoma. Dalley DN; Levi JA; Aroney RS Med J Aust; 1980 Mar; 1(5):216-8. PubMed ID: 6990214 [TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of two combination chemotherapy regimens containing doxorubicin in patients with metastatic breast cancer: a Western Cancer Study Group trial. Irwin LE; Chlebowski RT; Weiner JM; Reynolds R; Pugh RP; Ryden VM; Bateman JR Cancer Treat Rep; 1980; 64(8-9):981-4. PubMed ID: 7004635 [TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy of advanced breast cancer--actual results ]. Matthes ML; Lenk H; Gürtler R; Tanneberger S Arch Geschwulstforsch; 1982 May; 52(3):241-6. PubMed ID: 6812538 [TBL] [Abstract][Full Text] [Related]
13. [Primary chemotherapy in soft tissue sarcomas considered inoperable]. Rouëssé J; Le Chevalier T; Contesso G; Sarrazin D; Amiel JL; Sevin D; Carde P; Génin J Sem Hop; 1983 May; 59(19):1441-4. PubMed ID: 6310758 [TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations. Aisner J; Whitacre M; Van Echo DA; Wiernik PH Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987 [TBL] [Abstract][Full Text] [Related]
15. [Combined drug/hormone therapy in metastatic breast cancer with vincristine, adriamycin, cyclophosphamide and high dose medroxyprogesterone acetate--VAC-MAP. Preliminary results of a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force]. Wander HE; Nagel GA; Blossey HC; Kordilla F; Stamm S; Matthressen W; Weiss J Onkologie; 1982 Aug; 5 Suppl():8-12. PubMed ID: 6752794 [TBL] [Abstract][Full Text] [Related]
16. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer. Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034 [TBL] [Abstract][Full Text] [Related]
17. Phase II study of mitolactol in chemotherapy-refractory metastatic breast cancer. Creech RH; Catalano RB; Dierks KM; Shah MK Cancer Treat Rep; 1984 Dec; 68(12):1499-501. PubMed ID: 6548936 [TBL] [Abstract][Full Text] [Related]
18. Cyclical combination chemotherapeutic regimen in adult soft tissue sarcoma. Dalley DN; Levi JA; Nesbitt RA; Tattersall MH; Woods RL; Fox RM; Aroney RS Cancer Clin Trials; 1981; 4(2):163-5. PubMed ID: 7249252 [TBL] [Abstract][Full Text] [Related]
19. Prolonged disease-free survival in advanced breast cancer treated with "super-CMF" adriamycin: an alternating regimen employing high-dose methotrexate with citrovorum factor rescue. Henderson IC; Gelman R; Canellos GP; Frei E Cancer Treat Rep; 1981; 65 Suppl 1():67-75. PubMed ID: 6976832 [TBL] [Abstract][Full Text] [Related]
20. Combination of levamisole immunotherapy and polychemotherapy in advanced breast cancer. Klefström P Cancer Treat Rep; 1980 Jan; 64(1):65-72. PubMed ID: 6991105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]